IndraLab

Statements

OTUD5 inhibits doxorubicin. 1 / 1

| 1

➶

reach

"OTUD5 knockdown also enhanced the resistance of NSCLC cells to doxorubicin and cisplatin."

32248621

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

OTUD5 inhibits doxorubicin. 1 / 1

INDRA sources:

Databases

Reading